Growth and development of children with congenital heart disease

Chi-Wen Chen1, Chung-Yi Li, Jou-Kou Wang

  • 1Department of Nursing, Fu-Jen Catholic University, Taipei, Taiwan. nurs1010@mails.fju.edu.tw

Insights

Children with congenital heart disease (CHD) show delayed growth and developmental issues compared to healthy peers. Early detection and long-term support programs are crucial for these children.

Area of Science:

  • Pediatric Cardiology
  • Developmental Pediatrics
  • Child Health

Background:

  • Congenital heart disease (CHD) frequently leads to growth delays in children.
  • Assessing both growth and development is critical for monitoring children's progress.

Purpose of the Study:

  • To evaluate and compare the growth and development of preschool children with CHD against normal preschool children.
  • To identify specific developmental areas affected by CHD in early childhood.

Main Methods:

  • Compared height and weight of 42 preschoolers with CHD and 116 controls against standard growth curves.
  • Utilized the Denver Developmental Screening Test II to assess personal-social skills, fine motor skills, adaptability, language, and gross motor skills.
  • Noted potential cultural adaptations needed for the Denver II test in Taiwanese populations.

Main Results:

  • Preschoolers with CHD exhibited significantly lower height and weight percentiles compared to controls (P < 0.05).
  • Children with CHD showed more "suspicious" scores in language (P < 0.01) and gross motor (P < 0.001) domains.
  • Despite challenges, some personal-social and language skills were within normal ranges for children with CHD.

Conclusions:

  • Understanding growth and developmental differences aids early problem detection in children with CHD.
  • Long-term follow-up programs are recommended to support development and provide information for families.
  • Findings offer a reference for clinicians and community workers providing care to children with CHD.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...